Örn Almarsson
Chemist and Chief Technology Officer at Lyndra Therapeutics, USA
The presentation is about a journey in drug delivery for the past quarter century.
The talk is split into three parts, the first one being a brief summary of my background along with an introduction to injectable extended-release drug product design and development.The second portion of the talk, the most substantial one, is about messenger RNA vaccines, their design and action. The third and final portion is a short introduction to ultra long-acting oral delivery.
The talk concludes with reflections on the state of pharmaceutical R&D, integrating the presenters’ thoughts following my journey to date and life during a pandemic.